Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma

被引：1
|
作者：
Fozza, Claudio [1 ]
Galleu, Antonio [1 ]
Careddu, Maria Grazia [1 ]
Giannico, Domenica Barbara [1 ]
Bonfigli, Silvana [1 ]
Contini, Salvatore [1 ]
Longinotti, Maurizio [1 ]
机构：
[1] Univ Sassari, Inst Haematol, I-07100 Sassari, Italy
来源：
ANNALS OF HEMATOLOGY | 2010年 / 89卷 / 01期
关键词：
Chronic Lymphocytic Leukemia; Autoimmune Hemolytic Anemia; Kappa Light Chain; Macrocytic Anemia; Bone Marrow Smear;
D O I：
10.1007/s00277-009-0782-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 114
页数：2
相关论文
共 50 条
  • [21] SPLENECTOMY VERSUS RITUXIMAB IN THE TREATMENT OF SPLENIC MARGINAL ZONE LYMPHOMA
    Kalpadakis, C.
    Pangalis, G. A.
    Vassilakopoulos, T. P.
    Sachanas, S.
    Kyrtsonis, M. C.
    Dimopoulou, M.
    Korkolopoulou, P.
    Kontopidou, F. N.
    Yiakoumis, X.
    Siakantaris, M. P.
    Dimitriadou, E. M.
    Panayiotidis, P.
    Papadaki, H.
    Angelopoulou, M. K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 168 - 169
  • [22] Treatment of Splenic Marginal Zone Lymphoma: Splenectomy Versus Rituximab
    Bennett, Michael
    Schechter, Geraldine P.
    SEMINARS IN HEMATOLOGY, 2010, 47 (02) : 143 - 147
  • [23] Rituximab monotherapy is highly effective in splenic marginal zone lymphoma
    Bennett, Michael
    Yegena, Shaiy
    Dave, Harish P.
    Schechter, Geraldine P.
    HEMATOLOGICAL ONCOLOGY, 2008, 26 (02) : 114 - 114
  • [24] RITUXIMAB IN A PATIENT WITH SPLENIC MARGINAL ZONE LYMPHOMA AND ACQUIRED ANGIOEDEMA
    Motosue, M.
    Butterfield, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A61 - A62
  • [25] A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders
    Brisou, Gabriel
    Verney, Aurelie
    Wenner, Thomas
    Baseggio, Lucile
    Felman, Pascale
    Callet-Bauchu, Evelyne
    Coiffier, Bertrand
    Berger, Francoise
    Salles, Gilles
    Traverse-Glehen, Alexandra
    HAEMATOLOGICA, 2014, 99 (10) : E197 - E198
  • [26] Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Angelopoulou, Maria K.
    Sachanas, Sotirios
    Vassilakopoulos, Theodoros P.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (01) : 65 - 72
  • [27] A Woman with Splenomegaly and Anemia Splenic marginal-zone lymphoma, with an IgM paraprotein, antiphospholipid antibodies (lupus anticoagulant and IgM anticardiolipin antibody), and autoimmune hemolytic anemia.
    Abramson, Jeremy S.
    Chatterji, Manjil
    Rahemtullah, Aliyah
    Barnes, Jeffrey A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (25): : 2707 - 2718
  • [28] Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone
    Tsimberidou, Apostolia M.
    Catovsky, Daniel
    Schlette, Ellen
    O'Brien, Susan
    Wierda, William G.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Wen, Sijin
    Do, Kim-Anh
    Lerner, Susan
    Keating, Michael J.
    CANCER, 2006, 107 (01) : 125 - 135
  • [29] Treatment of Splenic Marginal Zone Lymphoma with Rituximab Monotherapy in 59 Patients
    Kalpadakis, Christina H.
    Pangalis, Gerassimos
    Vassilakopoulos, Theodoros P.
    Sachanas, Sotirios P.
    Kontopidou, Flora
    Yiakoumis, Xanthi
    Kokoris, Styliani
    Dimitriadou, Evangelia
    Dimopoulou, Maria
    Moschogiannis, Maria
    Korkolopoulou, Penelope
    Kyrtsonis, Marie-Christine
    Siakantaris, Marina
    Papadaki, Helen A.
    Angelopoulou, Maria K.
    BLOOD, 2011, 118 (21) : 1167 - 1167
  • [30] BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS SALVAGE THERAPY FOR SPLENIC MARGINAL ZONE LYMPHOMA
    Iannitto, E.
    Mancuso, S.
    Augello, A.
    Franco, G.
    Domingo-Domenech, E.
    Pennese, E.
    Vincenzo, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 524 - 524
12345